KE2 TECHOLOGIES BECOMES FLOSONICS MEDICAL

A medical device company focused on developing non-invasive sensors to improve the management of critically ill patients.

Our Technology

Flosonics is a medical device company focused on developing non-invasive sensors to improve the management of critically ill patients. Flosonics Medical’s flagship smart-bandage product, the FloPatch, addresses unmet clinical needs of critically ill patients and the physicians, nurses, and paramedics who care for them in the ambulance, emergency department, operating room, and intensive care unit.

 

WIRELESS ENABLED

WIRELESS ENABLED

Bluetooth connectivity to tablet, phone or other medical equipment.

COST EFFECTIVE DISPOSABLE ULTRASOUND BANDAGE

COST EFFECTIVE DISPOSABLE ULTRASOUND BANDAGE

Low cost disposable reduces the requirement of expensive capital purchases and maintenance.

FUNCTIONAL HEMODYNAMIC MONITORING

FUNCTIONAL HEMODYNAMIC MONITORING

Determine fluid responsiveness in under 30 seconds.

FLOW MONITORING

FLOW MONITORING

Continuous monitoring of arterial flow with automatic artery detection.

IMPROVE PHYSICIAN WORKFLOWS

IMPROVE PHYSICIAN WORKFLOWS

Hands free with simple push-button functionality. Small, portable and wireless.

REMOVE TECHNICAL BARRIERS

REMOVE TECHNICAL BARRIERS

Purpose built to be easily used by physicians, nurses and paramedics.

TEAM

Dr. Joe Eibl

Dr. Joe Eibl

CEO & Co-Founder

Dr. Eibl is responsible for the growth and development of technology, intellectual property and business strategy. Dr. Eibl holds a PhD in Biomolecular Sciences and he has conducted postdoctoral training in the field of bioengineering.

Dr. Jon-Emile Kenny

Dr. Jon-Emile Kenny

Chief Medical Officer & Co-Founder

Dr. Kenny obtained his M.D. at the University of Toronto. He completed his residency and chief residency in general internal medicine at NYU-Langone Medical Center. He completed his fellowship in pulmonary & critical care medicine at Stanford University Medical Center. Dr. Kenny is also the founder of Heart-Lung.org (a critical medical education website), and he is the Senior Contributing Editor for PulmCCM. Dr. Kenny will lead clinical evaluation, functionality and 510K certification of technology for approval by the Food and Drug Administration.

Andrew Eibl

Andrew Eibl

Director of Operations & Co-Founder

Mr. Andrew Eibl holds a Bachelor of Commerce from the University of Ottawa, and is currently pursuing the Canadian Human Resources Professional Designation. Mr. Eibl has over 7 years of experience in healthcare data analytics, human resources, project management, and business development. Previously, he managed a Human Resource Information System with over 2000 employees, and was a Data Specialist for health case costing at Health Sciences North.

Sachit Harish, CPA, CA

Sachit Harish, CPA, CA

Director of Finance and Co-Founder

Mr. Sachit Harish is a Chartered Professional Accountant (CPA, CA) with a strong background in start-up financing and growth. He previously spent over 5 years auditing a wide range of real estate, high-tech, manufacturing and private corporations at Deloitte LLP. More recently, he has worked in companies ranging from large high-tech corporations, to residential home-builders, in addition to  assisting with the startup and growth of a cryptocurrency company.

Board of Directors

Dr. Paul Magnin – Chairman of the Board

Dr. Paul Magnin – Chairman of the Board

Paul Magnin spent 17 years as a key contributor to Hewlett-Packard’s Ultrasound Imaging business, and he is credited with inventing color flow Doppler imaging. He was the R&D Manager of Hewlett-Packard’s Imaging Systems business from 1992 through 1995 and General Manager from 1996 through 1998. From 1999 through 2003, Dr. Magnin was the President and CEO of LightLab Imaging. LightLab Imaging, a medical device start-up company, brought to market a proprietary technology that employs infrared light to make images with resolution on the micron scale for Cardiology, Endoscopy, Neurology, and Surgical Microscopy. He managed the company from the start-up phase through the sale of the company to Goodman Ltd. Subsequently he was the Founder and CEO of Novelis, Inc. a privately funded start-up focused on guiding therapy for Interventional Cardiology applications. Novelis was sold to Volcano Corporation in 2008.

Dr. Magnin is an advisor and board member of a number of medical device start-up companies and was the Chairman of the Board of Directors of Ultrasonix Medical Corp. in Vancouver, BC. He holds over 20 patents and has authored over 20 scientific journal articles. He has been studying and working in medical imaging since 1977 while an undergraduate at Princeton University. In 1981 he completed his doctorate in Biomedical Engineering at Duke University where he was part of the Ultrasonic Imaging research team.

Dr. Stuart Foster – Director

Dr. Stuart Foster – Director

Stuart Foster is currently a senior scientist at Sunnybrook Research Institute and Professor and Canada Research Chair in Ultrasound Imaging, Department of Medical Biophysics at the University of Toronto. His current research centers on the development of high frequency clinical and preclinical imaging systems, array technology, intravascular imaging, photo acoustics, and molecular imaging. Stuart is a fellow of the American Institute of Ultrasound in Medicine and IEEE. He is the founder and former Chairman of VisualSonics Inc. which manufactures imaging equipment considered to be the gold standard in high frequency ultrasound. VisualSonics is now part of the Fujifilm group of companies. Dr. Foster co-founded the Mouse Imaging Centre (MICe) now at the Toronto Centre for Phenogenomics. He has served on the Board of Directors of the National Cancer Institute of Canada and as Chairman of its Committee on Research (ACOR). He has previously been the recipient of the Eadie Medal for major contributions to engineering in Canada and has been the recipient of the Queen’s Golden Jubilee Medal, the Manning Award of Distinction for Canadian Innovation and the Ontario Premier’s Discovery Award. He serves on numerous advisory bodies and is currently on the editorial boards of Ultrasonic Imaging and Ultrasound in Medicine and Biology. Dr. Foster was the recipient of the 2010 Rayleigh Award from IEEE.

Sam Ifergan

Sam Ifergan

Sam has over 20 years of entrepreneurial, technology and venture capital experience. As Managing Partner of the iGan Partners team, he is involved in the evaluation, structuring, execution, and monitoring of iGan’s investments. Sam has been extensively involved with several companies, often serving as CEO, particularly in the early stages of each company’s development. Prior to founding iGan Partners, he co-founded several companies including Visualsonics, Tri-Link Technologies and Brighter Minds. Prior to that he was a strategy consultant with Mercer Management Consulting (now Oliver Wyman) where he advised Fortune 500 companies on corporate strategy. Sam has also held general management roles at NCR, where he led the deployment of enterprise-grade information technology systems.

Sam holds an MBA from the John Molson School of Business and a Bachelor of Electrical Engineering from McGill University.

Dr. Joe Eibl

Dr. Joe Eibl

Director

Dr. Joe Eibl is the CEO and Co-founder of Flosonics Medical.

News

New Name and Identity Reflects Company’s Focus on Enabling a New Paradigm in Improving The Management of Critically Ill Patients
Read More
https://interfacechallenge.com/process/top-10/ https://www.linkedin.com/pulse/top-10-finalists-chosen-interface-health-challenge-x-2016-bidu    
Read More
Flosonics Medical wins Merck’s Displaying Futures Award and $50,000 USD Merck KGaA, Darmstadt, Germany, is presenting the second Displaying Futures Award to foster young entrepreneurs. The aim of this year’s call for proposals is to identify flexible applications in the f...
Read More

Flosonics Medical

  • 705-626-6419
  • info@flosonicsmedical.com
  • www.flosonicsmedical.com
  • 73 Elm St, Sudbury, ON P3C 1R7